Safety, immunogenicity and antibody persistence of a bivalent Beta-containing booster vaccine against COVID-19: a phase 2/3 trialSpyros Chalkias, Rituparna Das, Biliana Nestorova et al.|Nature Medicine|2022Cited by 144
Safety, Immunogenicity and Antibody Persistence of a Bivalent Beta-Containing Booster VaccineSpyros Chalkias, Rituparna Das, Frank Eder et al.|Research Square|2022Cited by 24